Rintis Noviyanti Selected Research

1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)

1/2018

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rintis Noviyanti Research Topics

Disease

28	Malaria 01/2022 - 08/2006
9	Infections 10/2020 - 03/2015
4	Vivax Malaria 01/2019 - 12/2014
3	Parasitemia 01/2022 - 12/2015
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2019 - 01/2014
3	Glucosephosphate Dehydrogenase Deficiency 01/2017 - 12/2014
1	Dengue (Dengue Fever) 10/2020
1	Birth Weight (Birth Weights) 01/2019
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2019
1	Placental Insufficiency 01/2019
1	Reinfection 01/2018
1	Fever (Fevers) 12/2016
1	Asymptomatic Infections 01/2016
1	Acute malaria 12/2015
1	Hemolytic Anemia 03/2015
1	Inflammation (Inflammations) 01/2014

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 12/2021 - 03/2013
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
5	Primaquine FDA Link 01/2018 - 12/2014
4	artemisinin (artemisinine)IBA 12/2020 - 01/2017
3	acetone hydrazoneIBA 11/2020 - 05/2018
2	Plasmodium falciparum erythrocyte membrane protein 1IBA 01/2022 - 05/2016
2	AntibodiesIBA 01/2022 - 05/2016
2	artenimol (dihydroartemisinin)IBA 12/2021 - 01/2018
2	piperaquineIBA 12/2021 - 01/2018
2	Antimalarials (Antimalarial Agents)IBA 01/2019 - 03/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2014
2	VaccinesIBA 01/2018 - 08/2006
2	Chloroquine (Aralen)FDA LinkGeneric 01/2018 - 09/2015
2	Messenger RNA (mRNA)IBA 12/2016 - 01/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2016 - 08/2015
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 03/2015 - 12/2014
1	Malaria VaccinesIBA 01/2022
1	AntigensIBA 10/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	ArtesunateIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	TabletsIBA 01/2018
1	MMV390048IBA 01/2018
1	ChromatinIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2018
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2018
1	DextrorphanIBA 01/2018
1	alpha-aminopyridineIBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Glucose-6-PhosphateIBA 01/2017
1	tafenoquineIBA 01/2017
1	Dihydroorotate DehydrogenaseIBA 12/2016
1	DSM265IBA 12/2016
1	EnzymesIBA 12/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2016
1	Leptin ReceptorsIBA 12/2016
1	Protein Isoforms (Isoforms)IBA 12/2016
1	ACT-451840IBA 10/2016
1	Guanosine Triphosphate (GTP)IBA 01/2015
1	DDD107498IBA 01/2015
1	Peptide Elongation Factor 2 (EF-2)IBA 01/2015
1	Doxycycline (Periostat)FDA LinkGeneric 12/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	AngiopoietinsIBA 01/2014
1	Angiopoietin-1IBA 01/2014
1	Angiogenic ProteinsIBA 01/2014
1	P-SelectinIBA 01/2014
1	6- Chloro- 7- methoxy- 2- methyl- 3- (4- (4- (trifluoromethoxy)phenoxy)phenyl)quinolin- 4(1H)- oneIBA 03/2013

Therapy/Procedure

5	Therapeutics 01/2019 - 03/2015
1	Splenectomy 01/2021
1	Oral Administration 01/2019